Sana Biotechnology (NASDAQ:SANA) Stock Rating Upgraded by Citizens Jmp
Sana Biotechnology (NASDAQ:SANA – Get Free Report) was upgraded by research analysts at Citizens Jmp from a “market perform” rating to an “outperform” rating in a research note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $5.00 target price on the stock. Citizens Jmp’s price objective indicates a potential upside of […]
More Stories
Envestnet Portfolio Solutions Inc. Sells 5,525 Shares of Brown & Brown, Inc. (NYSE:BRO)
Envestnet Portfolio Solutions Inc. decreased its position in Brown & Brown, Inc. (NYSE:BRO – Free Report) by 33.2% in the...
Natixis Advisors LLC Buys 10,024 Shares of Warner Bros. Discovery, Inc. (NASDAQ:WBD)
Natixis Advisors LLC grew its stake in shares of Warner Bros. Discovery, Inc. (NASDAQ:WBD – Free Report) by 3.6% during...
Envestnet Portfolio Solutions Inc. Acquires 482 Shares of Waters Co. (NYSE:WAT)
Envestnet Portfolio Solutions Inc. boosted its holdings in Waters Co. (NYSE:WAT – Free Report) by 15.5% during the fourth quarter,...
BKM Wealth Management LLC Acquires 495 Shares of NVIDIA Co. (NASDAQ:NVDA)
BKM Wealth Management LLC grew its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 8.9% in the...
Evergreen Wealth Management LLC Takes Position in NVIDIA Co. (NASDAQ:NVDA)
Evergreen Wealth Management LLC purchased a new stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) in the fourth quarter, according...
NVIDIA Co. (NASDAQ:NVDA) Holdings Lifted by Northstar Asset Management Inc.
Northstar Asset Management Inc. lifted its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 8.7% in the fourth quarter,...